SG/CALL/FRESENIUS MEDICAL CARE/66/0.1/21.06.24 Stock

Warrant

DE000SW1ESV9

Market Closed - Deutsche Boerse AG 15:47:11 2024-05-31 EDT
0.001 EUR -.--% Intraday chart for SG/CALL/FRESENIUS MEDICAL CARE/66/0.1/21.06.24
Current year-92.31%
Date Price Change
24-05-31 0.001 -.--%
24-05-30 0.001 -.--%
24-05-29 0.001 -.--%
24-05-28 0.001 -.--%
24-05-27 0.001 -.--%

Delayed Quote Deutsche Boerse AG

Last update May 31, 2024 at 03:47 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer Société Générale Société Générale
WKN SW1ESV
ISINDE000SW1ESV9
Date issued 2023-07-24
Strike 66
Maturity 2024-06-21 (20 Days)
Parity 10 : 1
Emission price 0.14
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.11
Lowest since issue 0.001
Spread 0.019
Spread %95.00%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
39.18 EUR
Average target price
39.92 EUR
Spread / Average Target
+1.89%
Consensus